HY-126077-1mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-126077-10mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-126077-100mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-126077-25mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-126077-5mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-126077-50mg
|
MedChemexpress LLC
|
MTI-31 [CAS 1567915-38-1]
|
|
COVID-19-immunoregulation
|
|
HY-P1821A-10mg
|
MedChemexpress LLC
|
Myelin Basic Protein (TFA)
|
|
Neuroscience-Neuromodulation
|
|
HY-P1821A-5mg
|
MedChemexpress LLC
|
Myelin Basic Protein (TFA)
|
|
Neuroscience-Neuromodulation
|
|
HY-133011-1mg
|
MedChemexpress LLC
|
nAChR agonist 1 [CAS 1394371-75-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-133011-10mg
|
MedChemexpress LLC
|
nAChR agonist 1 [CAS 1394371-75-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-133011-25mg
|
MedChemexpress LLC
|
nAChR agonist 1 [CAS 1394371-75-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-133011-5mg
|
MedChemexpress LLC
|
nAChR agonist 1 [CAS 1394371-75-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-133011-50mg
|
MedChemexpress LLC
|
nAChR agonist 1 [CAS 1394371-75-5]
|
|
Neuroscience-Neurodegeneration
|
|
HY-133011-1mL
|
MedChemexpress LLC
|
nAChR agonist 1 [CAS 1394371-75-5] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
HY-15030A-10g
|
MedChemexpress LLC
|
Naproxen (sodium) [CAS 26159-34-2]
|
|
COVID-19-immunoregulation
|
|
HY-15030A-5g
|
MedChemexpress LLC
|
Naproxen (sodium) [CAS 26159-34-2]
|
|
COVID-19-immunoregulation
|
|
HY-15030A-500mg
|
MedChemexpress LLC
|
Naproxen (sodium) [CAS 26159-34-2]
|
|
COVID-19-immunoregulation
|
|
HY-15030A-1mL
|
MedChemexpress LLC
|
Naproxen (sodium) [CAS 26159-34-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-15030-10g
|
MedChemexpress LLC
|
Naproxen [CAS 22204-53-1]
|
|
COVID-19-immunoregulation
|
|
HY-15030-5g
|
MedChemexpress LLC
|
Naproxen [CAS 22204-53-1]
|
|
COVID-19-immunoregulation
|
|
HY-15030-500mg
|
MedChemexpress LLC
|
Naproxen [CAS 22204-53-1]
|
|
COVID-19-immunoregulation
|
|
HY-15030-1mL
|
MedChemexpress LLC
|
Naproxen [CAS 22204-53-1] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-19675-10mg
|
MedChemexpress LLC
|
Naproxen etemesil [CAS 385800-16-8]
|
|
COVID-19-immunoregulation
|
|
HY-19675-100mg
|
MedChemexpress LLC
|
Naproxen etemesil [CAS 385800-16-8]
|
|
COVID-19-immunoregulation
|
|
HY-19675-25mg
|
MedChemexpress LLC
|
Naproxen etemesil [CAS 385800-16-8]
|
|
COVID-19-immunoregulation
|
|